andre- define "... a well regulated militia". All SCOTUS judges interpret the constitution to some extent.
And all are faced with changing events that challenge past ways of life during authorship of the original. Consider, all men are created equal...but women didn't get a vote and some men and women were considered property thus NOT equal.
We are far from perfect but we find a level of perfection by trying to be better. In this thought came other laws that patched the holes in the Constitution. And we continue in that process of patching, adding-subtracting to it everyday.
I often bring up Scalia's ruling in Gore vs Bush: if we allow Florida to recount in some counties we will deprive George Bush of his victory. Meaning- Florida blew it by NOT recounting all counties from the get go and now its too late.
Was Scalia being conservative or practical? I don't know but I don't care because his view is as valid as any and does NOT merit a political label-chi
Not talking FDA, I'm talking revs$ and expenses. And if you can't forecast revs$ within a discernible range you will always be wrong on expenses and if both of those happen, well then, you don't have a handle on your business. And when you don't have a HANDLE, the market has NOTHING to grab onto except an infrequent catalyst.
They provide NO guidance, therefore they don't know from one qtr to the next how the business will go--the handle is missing.
If they are certain the next qtr report will be down/backwards, then its smart to NOT speak about revenue BUT rather to address the expense side--that tells the market they are handling what needs to done to turn things around and move forward.
There's a good reason why we float at a $1 and that is LACK OF GUIDANCE/NO HANDLE ON THE BUSINESS. But If you have an alternate view as to their approach, then speak up lad--chi
Clarifying-- they know what they are doing product build wise, they don't know how that product build is going to deliver, therefore, they don't have a handle on the business...and if they did, wouldn't they be able to predict it much better and if they could, why haven't they...because they don't. IMO- chi
foog- how was he a great asset? They have no handle on their business OR if they do, they refuse to talk about it...therefore, the market is NON-PLUSSED/NOT INTERESTED/ AVOID LIKE THE PLAGUE.
The real CFO would know revs within a single digit %, would trim expenses by a single digit Q2Q and provide real cost estimates to the CEO to allow him to make wise expenditures when he feels the risk is worth it.
IMO, they do NOT have a handle on their business thus a noticeable lack of enthusiasm for the stock. I seriously don't get how they could be approaching the edge of BreakEvenQ2Q and they lack the desire to make that happen. That achievement would change everything.
So flirt with the listing bollinger bands, one mistake, either their fault or others and this goes back into delist territory very quickly. Why else is it floating on the $1 bubble? Anyone?-chi
namm- heard that...and still don't believe it. If you look at this company from a different angle, you might think; a real gem about to take off...but from every other angle, every other way, the SP is not gaining traction, there are NOT more people buying, the SP is floating and the company thinks they are doing great? So, yeah, maybe they don't dilute because of QST, maybe they dilute for a different reason.
Too many shares, too little revenue, not enough sizzle, somebody hid the steak...and the "shelf" is breaking--chi
LOKO- noooo, I am NOT stock dog, again, I post on this board as CHI.
IMO, they need a marketer on board. Its obvious. And one easy goal is to say: we are not going to dilute you, we'll cut salaries first. 150M shares is about 100M too much for the amt. of revenue.
As interest in ATRS fades, shorts will again be encouraged to prey if this ever gets to $1.5, meanwhile, ATRS thinks they are doing great, shareholders think they are delusional, thus we have a chasm of mis-alignment...never good for a stock. I think its time to hibernate until they are ready to announce they submitted QST to FDA and we have "something we think is just peaches and cream..."-chi
loko- no, I don't change alias on ATRS board. But I do think a partner is in the works for QST but why oh why oh why wait to announce that? OK, maybe timing to sub. to FDA would be appropriate. So again, key questions is size of payment for ROW to FUND USA self marketing...me thinks el market thinks- they will dilute to self fund QST.
Bigger problem, market is given only slightly positive phrases: we think it will really perform or we are very excited about the prospects or it could really add a lot or we have much to be excited about. That leaves the market NON-INFORMED and NOT INTERESTED.
Second big problem: market does not believe they are good self marketers of their direct sale products so there is no reward awaiting ATRS upon announcements/events.
Third problem: they refuse to issue any guidance, even broad range guidance or even date ranges, aside from submitting QST before end of 16.
Fourth problem: Does TEVA have the EPI problem or does TEVA have the EPI problem because of ATRS?
Fifth problem: short interest slightly bumped up but days to cover has really grown as ave. vol. is dropping meaning interest in waning not warming. This is a reflection of problems #1-4.
Its a case of ATRS- GET OFF YOUR DUFF AND HELP YOURSELF BY ISSUING GOALS AND HITTING GOALS AND IF YOU CAN'T HIT ANY GOAL, THEN SELL THE DAM COMPANY CUZ YOU AIN'T RUNNING A BUSINESS--chi
namm...a matrix or possibles;
- Recent new product entered market behind TEVA's marketing
- human factors study looking at completion, IMO- end of sept.
- mystery project could be announced
- QST partner is a huge possible...
- IF a QST partner is named, it reduces chance of secondary.
-Otrex update could be positive but I give this 50-50
- loss per share under 5 cents? Possible...
- other partner projects have advanced and may be looking more positive than projected or not.
- TEVA's new stable of drugs...oh yes, they have to be a talking...they've had forever to lay it out
- company may be able to project a B/E qtr for mid '17...if they have a QST diet./mktg partner who knows what they are doing.
- EPI update?
- E-V of $150M...with a two year forward rev. run rate of over $150M makes this $1 to $2.50 SP a joke, a undervalued joke...again, they can push rev. up very fast with EPI and QST both in channels.
Of course all of these positives could be negatives or neutrals too...-- chi
There has to be at least 2 vials a-waiting the scorpion's needle.
Now, would it be too much to ask for the company to at least identify a # of drugs in the Activis "pile" that should be injected? Not saying which, not saying they will but just to show us that they are paying attention...
And let us know if QST Human Factors wraps up by end of Sept...and of course, sales tracking with course changes if sales are NOT turning UP to the extent the company expected.
Lastly, who is the QST marketing partner because I think they have proven they CANNOT market on their own...-chi
Prevailing wisdom does agree with your view: too many positives building up for it to go negative.
But if the market thought that ATRS' revenues were about to double in a years time, the SP would be a lot higher. They gain approvals and the SP sinks ( short position held the reins), now the shorts are about finished here OR not, if the company doesn't get to profitability and ink a deal for QST distribution/sales.
If they knew what being B-E means, they would strive for that much harder. Rev. going up, Exp. going up...goal is keep rev going faster up and moderate Exp. going up...I don't think they agree with that. At this time--chi
LOKO- Its a very interesting series of patents--like a gun w/ cartridges for diabetics...makes for nice razor and blade sale potential ( the best club I ever joined- the dollar shave club).
Agree that hiding the light in a coal mine is NOT thinking on the part of ATRS- I can only think of one plausible reason to NOT PR that...an agreement is pending. Which if true, is a double shot of juice: the partner and the product that fills the agreement.
The SP is at a dollar for a reason-- MGT. GET OFF YOUR DUFFS AND DO SOMETHING OR ELSE IT CRATERS AGAIN. Short interest is currently lowest in a long time BUT if that reverses AGAIN...well, its a sad story Chapter 5 called MORE OF THE LAME--chi
Loko- great points...and worth a signed letter from Shareholders to Mgtment.
They have landed new projects, increased revs., pointed to opportunities, lined up approaching FDA subs...and the shorts still trampled this stock.
Now, the short position is under 5% so some bit of perception is turning along with the approaching FDA QST sub. Further up the road, TEVA's huge acq. is a month away from final transfer...so now is the time for the company to communicate, to tighten expenses, to re-look at any sales effort that is NOT succeeding and change the approach or the price or the position.
Just Breakeven triples the stock so THAT is a worthy short term, in 2016, goal. If they do that in Q4, file the FDA QST sub. in Q4...then the stock becomes very very attractive.
A letter from shareholders to mgt...lets work on the top 5 requests that are within reach and why we perceive them to be important. Smart mgt. would love to hear the truth and would embrace it.
Point #1, evaluate sales on a week to week basis and when goals are NOT hit, find out why and re-adjust and keep re-adjusting until reasonable goals are hit. AND if by chance, goals are being reached, find out why and amplify the drivers.
I now leave the floor open to any fellow shareholder with a real desire to speak as one to mgt....-chi